4//SEC Filing
Sucampo Pharmaceuticals, Inc. 4
Accession 0001171843-14-004349
CIK 0001365216operating
Filed
Sep 14, 8:00 PM ET
Accepted
Sep 15, 5:20 PM ET
Size
7.4 KB
Accession
0001171843-14-004349
Insider Transaction Report
Form 4
Claiborne Cary J
Chief Financial Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2014-09-11+25,000→ 149,987 totalExercise: $6.75From: 2018-09-11Exp: 2024-09-11→ Class A Common Stock (25,000 underlying) - Award
Employee Stock Option (Right to Buy)
2014-09-11+22,027→ 124,987 totalExercise: $6.75Exp: 2024-09-11→ Class A Common Stock (22,027 underlying)
Footnotes (2)
- [F1]The option vests in four equal annual installments beginning on September 11, 2015.
- [F2]Performance Conditions for accelerated vesting: One third of the Total Award may vest prior to the Vesting Date each time the Compensation Committee approves management's recommendation that certain pre-determined targets have been achieved in one of the three categories of strategic objectives of the Company.
Issuer
Sucampo Pharmaceuticals, Inc.
CIK 0001365216
Entity typeoperating
Related Parties
1- filerCIK 0001365216
Filing Metadata
- Form type
- 4
- Filed
- Sep 14, 8:00 PM ET
- Accepted
- Sep 15, 5:20 PM ET
- Size
- 7.4 KB